NCT04683198 2020-12-24
Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC
ChineseAMS
Phase 2 Unknown
Clinical Trials
5 trialsNCT04661696 2020-12-10
Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.
ChineseAMS
Phase 2 Unknown
NCT03735082 2018-11-08
Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT02041338 2014-11-25
Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01276769 2011-11-16
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown